Red X iconGreen tick iconYellow tick icon

Jo Gullam Dr Joanna (Jo) Gullam MBChB DFFP MRCOG MD (Warwick) FRANZCOG

Head of Department
Senior Lecturer
Specialist Obstetrician

Department of Obstetrics and Gynaecology, Chritstchurch; Ōtākou Whakaihu Waka, Ōtautahi
Te Whatu Ora, Health New Zealand: Waitaha
RANZCOG Director of Fellowship Exams

Email joanna.gullam@otago.ac.nz
Tel +64 3 364 4807

Dr Gullam is a UK-trained obstetrician with specialist expertise in high-risk obstetrics and maternal medicine. She joined Ōtākou Whakaihu Waka, Ōtautahi in 2011 and was appointed Head of the Department of Obstetrics and Gynaecology in 2016. Alongside her academic role, she works clinically at Health NZ: Waitaha as the birth suite lead obstetrician and runs clinics focussing on maternal medicine. Further to this, she is actively involved in clinical governance and guideline development.

Dr Gullam completed her undergraduate medical degree and postgraduate specialist training in the United Kingdom, where she also earned her doctorate in myometrial physiology with a focus on preterm birth. She holds advanced certification in maternal medicine, high-risk obstetrics and labour ward lead.

Her clinical and research expertise lies in the intersection of maternal medicine, perinatal health, and translational clinical trials. She has been actively involved in numerous national and international multicentre trials aimed at improving outcomes in complex pregnancies. She serves as the Aotearoa, New Zealand representative on the International Saving Lives through Safer Birth steering committee.

She is also committed to medical education and training, serving as the Director of Fellowship Examinations for the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) since 2020, the convener for the fifth-year medical student programme at Otago, and a supervisor for undergraduate and postgraduate research students.

Research interests

  • Maternal medicine and perinatal health
  • High-risk obstetrics
  • Myometrial physiology and preterm birth
  • Fetal growth restriction and placental function
  • Angiogenic biomarkers (e.g. sFlt-1/PlGF) in pregnancy
  • Maternal immunisation and neuroprotection
  • Multicentre clinical trials in maternal–fetal health

She leads the obstetric and perinatal research team, contributing to research that informs evidence-based practice in perinatal health across Australasia.

Selected current and recent research involvement

  • APTS (Australian Placental Transfusion Study)
  • MAGENTA (Magnesium Sulphate at 30 to 34 weeks)
  • STRIDER NZAus (Sildenafil in early-onset FGR)
  • MBM Trial (My Baby's Movements)
  • PINTO (Pre-diabetes in pregnancy)
  • MATISSE RSV vaccine in pregnancy study: "Does Respiratory Syncytial Virus vaccine in pregnancy protect babies against lung disease?" (Pfizer, USA)
  • C*STEROID and PRECEDE (Antenatal corticosteroids prior to planned caesarean)

Teaching and leadership

  • Head of Department, Obstetrics and Gynaecology, University of Otago (2016–present)
  • Convener, 5th-Year O&G Medical Programme, University of Otago, Christchurch
  • Clinical Lead, Birth Suite, Te Whatu Ora | Health NZ: Waitaha
  • Director of Fellowship Examinations, RANZCOG

Publications

Hughes, R., MacKay, D., Gullam, J., & Florkowski, C. (2025). DIPPS stidu: Diabetes in pregnancy: Routine screening for placental insufficiency using the sFlt-1/PlGF. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1619), (pp. 90). Retrieved from https://nzmj.org.nz/ Conference Contribution - Published proceedings: Abstract

Hughes, R. C. E., Kyle, P., Phillips, I., Florkowski, C. M., & Gullam, J. (2025). In suspected fetal growth restriction, sFlt-1/PlGF and PlGF may have value in risk stratification for preterm birth and birthweight < 3rd centile: A blinded cohort study. Australian & New Zealand Journal of Obstetrics & Gynaecology. Advance online publication. doi: 10.1111/ajo.70003 Journal - Research Article

Simões, E. A. F., Pahud, B. A., Madhi, S. A., Kampmann, B., Shittu, E., Radley, D., … Gullam, J., … on behalf of the MATISSE (Maternal Immunzation Study for Safety and Efficacy) Clinical Trial Group. (2025). Efficacy, safety, and immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial. Obstetrics & Gynecology, 145(2), 157-167. doi: 10.1097/aog.0000000000005816 Journal - Research Article

Hughes, R., Phillips, I., Florkowski, C. M., & Gullam, J. (2024). Could the sflt-1/PLGF ratio have added value in the detection and management of small for gestational age and fetal growth restriction? A prospective blinded observational study. Journal of Paediatrics & Child Health, 60(Suppl. 1), (pp. 41). doi: 10.1111/jpc.16526 Conference Contribution - Published proceedings: Abstract

Crowther, C. A., Ashwood, P., Middleton, P. F., McPhee, A., Tan, T., Harding, J. E., for the MAGENTA Study Group, including Austin, N., Darlow, B. A., Dixon, B., Gullam, J., Leishman, D., Dawson, P., Devenish, C., Gaerty, K., Tomlinson, P. A., & Miller, H. (2023). Prenatal intravenous magnesium at 30-34 weeks' gestation and neurodevelopmental outcomes in offspring: The MAGENTA randomized clinical trial. JAMA, 330(7), 603-614. doi: 10.1001/jama.2023.12357 Journal - Research Article

Back to top